EUCTR2006-002369-37-LT进行中（未招募）不适用
ot-to-Lot Consistency Study of the Investigational, Split-virion, Inactivated Influenza Vaccine, Administered by the Intradermal Route in Adults.
Sanofi Pasteur SA0 个研究点目标入组 2,250 人开始时间: 2006年6月28日最近更新:
适应症
相关药物
试验速览
- 阶段
- 不适用
- 状态
- 进行中（未招募）
- 发起方
- 入组人数
- 2,250
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional clinical trial of medicinal product
入排标准
- 性别
- All
入选标准
- •1) Aged 18 to 60 years on the day of inclusion
- •2) Informed consent form signed
- •3) Able to attend all scheduled visits and to comply with all trial procedures
- •4) For a woman, inability to bear a child or negative urine pregnancy test at the first visit (V0)
- •Are the trial subjects under 18? no
- •Number of subjects for this age range:
- •F.1.2 Adults (18-64 years) yes
- •F.1.2.1 Number of subjects for this age range
- •F.1.3 Elderly (>=65 years) no
- •F.1.3.1 Number of subjects for this age range
排除标准
- •1) Systemic hypersensitivity to egg proteins, chick proteins, or any of the vaccine components, in particular, neomycin, formaldehyde, and octoxinol 9, or history of a life-threatening reaction to the trial vaccine or a vaccine containing the same substances
- •2) Febrile illness (oral temperature = 37.5°C, or rectal equivalent temperature =°38.0°C) on the day of inclusion
- •3) Participation in another clinical trial in the 4 weeks preceding the trial vaccination
- •4) Planned participation in another clinical trial during the present trial period
- •5) Congenital or acquired immunodeficiency, immunosuppressive therapy such as anti-cancer chemotherapy or radiation therapy within the preceding 6 months, or long-term systemic corticosteroids therapy
- •6) Unstable chronic illness (defined as illness requiring hospitalization or a clinically significant change in medication in the 12 weeks prior to inclusion) at a stage that could interfere with trial conduct or completion
- •7) Current abuse of alcohol or drug addiction that may interfere with the subject’s ability to comply with trial procedures
- •8) Blood or blood-derived products received in the past 3 months
- •9) Any vaccination in the 4 weeks preceding the trial vaccination
- •10) Vaccination planned in the 4 weeks following the trial vaccination
- •11) Previous vaccination against influenza (in the previous 6 months)
- •12) Thrombocytopenia or bleeding disorder contraindicating intramuscular vaccination
- •13) Subject deprived of freedom by an administrative or court order, or in an emergency setting, or hospitalized without his/her consent
研究者
相似试验
进行中（未招募）
1 期
ot-to-Lot Consistency Study of the Investigational, Split-virion, Inactivated Influenza Vaccine, Administered by the Intradermal Route in Adults.EUCTR2006-002369-37-GBSanofi Pasteur SA2,255
招募中
不适用
Comparison of neuromuscular monitorings (TOF-Watch SX versus Philips NMT Module) in patients undergoing rhinoplasty or rhinoseptoplasty.patients undergoing rhinoplasty or rhinoseptoplasty under general anaesthesicACTRN12617000625370CHU UCL Namur - Mont-Godinne30
招募中
不适用
Comparison of neuromuscular monitorings (TOF-Watch SX stabilised in the SL TOF tube versus Philips NMT Module stabilised in Philips Hand Adaptor ) in patients undergoing rhinoplasty or rhinoseptoplasty.patients undergoing rhinoplasty or rhinoseptoplasty under general anaesthesicACTRN12617001151325CHU UCL Namur - Mont-Godinne30
进行中（未招募）
不适用
Clinical application of continuous cuffless blood pressure monitoring based on optically measured changes in light absorption by blood vesselsHypertensionISRCTN13366089Department of Hypertension & Vascular Disease, The First Affiliated Hospital, Sun Yat-Sen University300
招募中
不适用
The Study of Reliability and Validity of Pattern Identifications Tool for Cognitive Disorders(PIT-C)Mental and behavioral disordersKCT0003419Dunsan Korean Medicine Hospital of Daejeon University60